Registry of patients with antiphospholipid antibodies
Constitution d'Une Collection d'Echantillons Biologiques Associee a Une Base de Donnees de Patients Possedant Des Anticorps Antiphospholipides
This study is creating a registry to track adults with antiphospholipid antibodies to better understand their health and gather important information over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 2 sites (Lille and 1 other locations) |
| Trial ID | NCT04308564 on ClinicalTrials.gov |
What this trial studies
This study aims to create a comprehensive registry for patients who test positive for antiphospholipid antibodies. Utilizing a web-based application called REDCap, the study collects data on patient demographics, clinical characteristics, and laboratory results related to antiphospholipid syndrome. Eligible participants are adults aged 18 to 60 who have shown persistent positivity for specific antiphospholipid antibodies. Patients will be monitored annually for clinical updates and blood samples will be collected for further analysis.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 60 who have persistent positivity for antiphospholipid antibodies.
Not a fit: Patients who are pregnant or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of antiphospholipid syndrome and improve patient management.
How similar studies have performed: While this approach is observational and builds on existing knowledge, similar registries have shown success in improving patient outcomes in related conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age between 18 and 60 years; * persistent (at least 12 weeks apart) aPL-positivity within 12 months prior to screening Exclusion Criteria: * no inform consent * impossible follow up * pregnancy
Where this trial is running
Lille and 1 other locations
- CHRU de Lille — Lille, France (Not_yet_recruiting)
- CHRU de Nancy — Nancy, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.